Results 221 to 230 of about 350,037 (355)

Knowledge of Pulmonary Tuberculosis among the Patients under Anti- Tubercular Therapy

open access: diamond, 2018
Golam Sagir   +4 more
openalex   +1 more source

Pulmonary aspergilloma: a treatment challenge in sub-saharan Africa. [PDF]

open access: yes, 2013
AM Baciewicz   +20 more
core   +3 more sources

Cytomegalovirus Infection After Chimeric Antigen Receptor T‐Cell Therapy or Bispecific Antibody Treatment for Hematologic Malignancies

open access: yesTransplant Infectious Disease, EarlyView.
This retrospective study analyzed the incidence of CMV infections among 179 patients who received CAR T‐cell or BsAb therapy for hematologic malignancies. CMV infections occurred in 43% in CAR T‐cell and 62% in BsAb recipients, with 1–4% progressing to CMV diseases.
Juhui Han   +5 more
wiley   +1 more source

A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampicin-Resistant Pulmonary Tuberculosis

open access: green
Veronique de Jager   +12 more
openalex   +2 more sources

Risk factors for cholera mortality: A scoping review

open access: yesTropical Medicine &International Health, Volume 30, Issue 5, Page 332-350, May 2025.
Abstract Objectives Cholera is an easily treatable disease, but many people are still unnecessarily dying from it. To improve current case management practices and prevent mortality requires a comprehensive understanding of who is at higher risk of dying.
Despina Pampaka   +4 more
wiley   +1 more source

Risk Factors of Pulmonary Tuberculosis in Aseer Region, Saudi Arabia: A Case-Control Study. [PDF]

open access: yesHealthcare (Basel)
Alsulayyim FS   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy